National Institute on Drug Abuse; Amended Notice of Meeting, 67774 [2023-21645]

Download as PDF 67774 Federal Register / Vol. 88, No. 189 / Monday, October 2, 2023 / Notices can be accessed from the NIH Videocast at the following link: https://videocast. nih.gov/. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. lotter on DSK11XQN23PROD with NOTICES1 Name of Committee: National Arthritis and Musculoskeletal and Skin Diseases Advisory Council. Date: January 30, 2024. Open: 9 a.m. to 1 p.m. Agenda: Discussion of Program Policies and Issues. Place: National Institutes of Health, Building 31, 6C Room A & B 31, Center Drive, Bethesda, MD 20892, (Hybrid Meeting). Closed: 2 to 4 p.m. Agenda: To review and evaluate grant applications and/or proposals. Place: National Institutes of Health, Building 31, 6C Room A & B 31, Center Drive, Bethesda, MD 20892. Contact Person: Darren D. Sledjeski, Ph.D., Director Division of Extramural Activities (DEA), National Institute of Arthritis and Musculoskeletal and Skin Diseases, 6701 Democracy BLVD, Bethesda, MD 20892, (301) 451–7766, darren.sledjeski@nih.gov. In the interest of security, NIH has procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors attending a meeting on campus or at an off-campus federal facility will be asked to show one form of identification (for example, a governmentissued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: https:// www.niams.nih.gov/about/working-groups/ advisory-council, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.846, Arthritis, Musculoskeletal and Skin Diseases Research, National Institutes of Health, HHS) Dated: September 26, 2023. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–21588 Filed 9–29–23; 8:45 am] BILLING CODE 4140–01–P VerDate Sep<11>2014 18:41 Sep 29, 2023 Jkt 262001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Drug Abuse; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Institute on Drug Abuse Special Emphasis Panel, October 31, 2023, 12:00 p.m. to October 31, 2023, 2:00 p.m., National Institute on Drug Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 which was published in the Federal Register on September 25, 2023, FR Doc 2023– 20693, 88–FR 65696. This notice is being amended to change the agenda from reviewing and evaluating grant applications to reviewing and evaluating contract proposals. The meeting date, time and location will remain the same. The meeting is closed to the public. Dated: September 26, 2023. Tyeshia M. Roberson-Curtis, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–21645 Filed 9–29–23; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Aging; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Aging Special Emphasis Panel; ADRD Etiology. Date: October 31, 2023. Time: 10:30 a.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Sandhya Sanghi, Ph.D., Scientific Research Officer, 7201 Wisconsin Avenue (2N230), NIA/SRB, Bethesda, MD PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 20814, (301) 496–2879, sandhya.sanghi@ nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS) Dated: September 26, 2023. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–21616 Filed 9–29–23; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director, National Institutes of Health; Notice of Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Office of AIDS Research Advisory Council. The meeting will be held as a virtual meeting and will be open to the public as indicated below. Individuals who plan to view the virtual meeting and need special assistance or other reasonable accommodations to view the meeting, should notify the Contact Person listed below in advance of the meeting. The meeting can be accessed from the NIH Videocast at the following link: https://videocast.nih.gov/. Name of Committee: Office of AIDS Research Advisory Council. Date: October 26, 2023. Time: 12:15 p.m. to 5:00 p.m. Agenda: The 64th meeting of the Office of AIDS Research Advisory Council (OARAC) will focus on HIV and health disparities, guest speakers and a discussion panel. The agenda will include OAR Director’s Report; updates on the Clinical Guidelines Working Groups of OARAC; updates on NIH HIVrelated advisory councils; the NIH HIV Strategic Plan for HIV and HIV-related Research report out; and public comment. Place: Office of AIDS Research, Office of the Director, NIH, 5601 Fishers Lane, Rockville, MD 20852 (Virtual Meeting), https://videocast.nih.gov/watch=49574. Contact Person: RDML Timothy H. Holtz, MD, MPH, Office of AIDS Research, Office of the Director, NIH, 5601 Fishers Lane, Room 2E61, Rockville, MD 20852, (301) 496–0357, OARACinfo@nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: www.oar.nih.gov, where an agenda and any additional information for the meeting will be posted when available. E:\FR\FM\02OCN1.SGM 02OCN1

Agencies

[Federal Register Volume 88, Number 189 (Monday, October 2, 2023)]
[Notices]
[Page 67774]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-21645]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the National 
Institute on Drug Abuse Special Emphasis Panel, October 31, 2023, 12:00 
p.m. to October 31, 2023, 2:00 p.m., National Institute on Drug Abuse, 
301 North Stonestreet Avenue, Bethesda, MD 20892 which was published in 
the Federal Register on September 25, 2023, FR Doc 2023-20693, 88-FR 
65696.
    This notice is being amended to change the agenda from reviewing 
and evaluating grant applications to reviewing and evaluating contract 
proposals. The meeting date, time and location will remain the same. 
The meeting is closed to the public.

    Dated: September 26, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-21645 Filed 9-29-23; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.